General Electric Company, Valeant Pharmaceuticals Intl Inc.: Billionaire William Ackman's Recent Comments
U.S. stock market have endured wild swings over the past few months, and some may wonder what has been driving equities so violently.
Valeant Pharmaceuticals International (VRX)
Market is closed
News
- First
- << Previous
- 151 - 160
- Next >>
What Hedge Funds Think of Valeant as It Tries to Increase Shareholder Value?
In two separate articles published this weekend, the New York Times noted how Valeant Pharmaceuticals Intl Inc (NYSE:VRX) management has cut R&D, raised drug prices, and avoided unnecessary taxes in its...
Valeant Could Face Subpeona But Here's Why You Should Buy It Anyway
You can add millions of angry (and poorer) investors to the list of people who really dislike Martin Shkreli at the moment.
Here's Why Hedge Funds Like Valeant Pharmaceuticals Intl Inc (VRX)
Barring for a few tech names, there are very large-cap stocks that can match the returns that the stock of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has generated over the past few years.
Billionaires See A Healthy Future For These Healthcare Stocks
The S&P 500 Health Care Index has advanced by 21.11% over the past three-year period, which is significantly higher than the S&P 500’s return of 10.30% over the same time span.
Ackman Still Confident Herbalife Ltd. (HLF) Will Fall; Discusses Mondelez International Inc (MDLZ), Valeant Pharmaceuticals Intl Inc (VRX)
Renowned activist investor Bill Ackman of Pershing Square was having another one of his wonderful years, clocking in a gross return of 13.0% on a year-to-date basis through July, compared to the 3.4% ...
Hedge Funds Are Hoarding Shares Of These Large-Caps
With the latest round of 13F filings in the books, hedge funds’ moves relating to different stocks and sectors during the second quarter are now available to those with the data at their disposal.
Billionaire Paulson's Top Healthcare Picks Include Allergan PLC (AGN), Valeant Pharmaceuticals Intl Inc (VRX) & Shire PLC (ADR) (SHPG)
John Paulson’s Paulson & Co. is a hedge fund that specializes in credit strategies, mergers, and event-driven arbitrage. Paulson & Co.
ValueAct Capital's Top Stock Picks Heading Into Q3
In its most recent 13F filing with the SEC for the reporting period quarter ending June 30, Jeffrey Ubben's ValueAct capital revealed an equity portfolio worth nearly $19 billion. Mr.
Apple Inc. (AAPL), Valeant Pharmaceuticals Intl Inc (VRX) Among Steadfast Capital's Top New Picks
Robert Pitts' Steadfast Capital Management recently filed its 13F with the Securities and Exchange Commission (SEC).
- First
- << Previous
- 151 - 160
- Next >>
Billionaire Hedge Funds
